We are live on ! Find out more
ESLA icon

Estrella Immunopharma
ESLA

8 hedge funds and large institutions have $8.09M invested in Estrella Immunopharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.02% less ownership

Funds ownership: 32.82% → 32.8% (-0.02%)

38% less funds holding

Funds holding: 13 → 8 (-5)

59% less capital invested

Capital invested by funds: $19.7M → $8.09M (-$11.6M)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
8
Holders Change
-5
Holders Change %
-38.46%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
–
Reduced
1
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
Robinson Capital Management
Michigan
+$247K
2
CM
Crestline Management
Texas
+$230K
3
SOA
Sea Otter Advisors
Florida
+$147K

Top Sellers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
-$8.87M
2
Nomura Holdings
Nomura Holdings
Japan
-$2.02M
3
LCM
Landscape Capital Management
New Jersey
-$516K
4
Citigroup
Citigroup
New York
-$502K
5
CSS
Cubist Systematic Strategies
Connecticut
-$209K
Name Holding Trade Value Shares
Change 		Change in
Stake
HHGC
1
Hunting Hill Global Capital
New York
$3.06M – – –
OCAM
2
Owl Creek Asset Management
New York
$2.7M – – –
SIA
3
SkyView Investment Advisors
New Jersey
$1.33M – – –
MC
4
Meteora Capital
Florida
$263K -$62.7K -5,999 -19%
RCM
5
Robinson Capital Management
Michigan
$250K +$247K +23,610 New
CM
6
Crestline Management
Texas
$233K +$230K +21,990 New
SOA
7
Sea Otter Advisors
Florida
$148K +$147K +14,026 New
YCM
8
Yakira Capital Management
Connecticut
$108K – – –
KIM
9
Karpus Investment Management
New York
– -$8.87M -863,249 Closed
Nomura Holdings
10
Nomura Holdings
Japan
– -$2.02M -197,000 Closed
LCM
11
Landscape Capital Management
New Jersey
– -$516K -50,105 Closed
Citigroup
12
Citigroup
New York
– -$502K -48,825 Closed
CSS
13
Cubist Systematic Strategies
Connecticut
– -$209K -20,276 Closed
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
– -$178K -17,335 Closed
Millennium Management
15
Millennium Management
New York
– -$123K -12,000 Closed
UBS Group
16
UBS Group
Switzerland
– -$7.78K -756 Closed

ESLA Hedge Fund Activity: Q1 2023 in Review

8 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma (ESLA) for Q1 2023, worth a combined $8.09M — down 59% from $19.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ESLA and 3 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Robinson Capital Management, opening a new position worth an estimated $247K. The largest seller was Karpus Investment Management, exiting entirely with an estimated $8.87M sold.

  • 8 institutional investors held Estrella Immunopharma (ESLA) as of Q1 2023, down from 13 in Q4 2022.
  • Funds reported $8.09M of Estrella Immunopharma stock for Q1 2023, down 59% quarter-over-quarter.
  • 3 funds opened new Estrella Immunopharma positions in Q1 2023 and 8 closed out, a net change of -5 holders.
  • The largest Estrella Immunopharma buyer in Q1 2023 was Robinson Capital Management, an estimated $247K added.
  • The largest Estrella Immunopharma seller in Q1 2023 was Karpus Investment Management, an estimated $8.87M sold.

Based on aggregated 13F filings for Q1 2023.